Global Drugs for the Treatment of Asthma Sales Market Report to 2021

November 2016 | 105 pages | ID: G7468033A63EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Drugs for the Treatment of Asthma

Revenue, means the sales value of Drugs for the Treatment of Asthma

This report studies sales (consumption) of Drugs for the Treatment of Asthma in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Novartis
• Pfizer, Inc.
• Roche
• Sanofi
• Merck & Co., Inc.
• GlaxoSmithKline plc
• Johnson & Johnson
• AstraZeneca plc.
• Eli Lilly and Company
• Abbvie
• AMGen
• Teva Pharmaceutical Industries Ltd.
• Bayer AG
• Bristol-Myers Squibb
• Astellas Pharma
• Daiichi Sankyo
• Abbott Laboratories
• Yangtze River Pharmaceutical Group
• BAX
• Taishō Seiyaku Kabushiki-gaisha

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Drugs for the Treatment of Asthma in these regions, from 2011 to 2021 (forecast), like

• North America
• China
• Europe
• Japan
• Southeast Asia
• India

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Beta2 Adrenergic Receptor Agonist
• M Cholinergic Receptor Antagonist
• Drugs that Affect Leukotrienes
• Glucocorticoid Drugs
• Phosphodiesterase Inhibitors

Split by applications, this report focuses on sales, market share and growth rate of Drugs for the Treatment of Asthma in each application, can be divided into

• First Level Hospital
• Two Level Hospital
• Three Level Hospital
• Others

Contents

Global Drugs for the Treatment of Asthma Sales Market Report 2021

1 DRUGS FOR THE TREATMENT OF ASTHMA OVERVIEW

1.1 Product Overview and Scope of Drugs for the Treatment of Asthma
1.2 Classification of Drugs for the Treatment of Asthma
  1.2.1 Beta2 Adrenergic Receptor Agonist
  1.2.2 M Cholinergic Receptor Antagonist
  1.2.3 Drugs that Affect Leukotrienes
  1.2.4 Glucocorticoid Drugs
  1.2.5 Phosphodiesterase Inhibitors
1.3 Applications of Drugs for the Treatment of Asthma
  1.3.1 First Level Hospital
  1.3.2 Two Level Hospital
  1.3.3 Three Level Hospital
  1.3.4 Others
1.4 Drugs for the Treatment of Asthma Market by Regions
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Drugs for the Treatment of Asthma (2011-2021)
  1.5.1 Global Drugs for the Treatment of Asthma Sales, Revenue and Price (2011-2021)
  1.5.2 Global Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
  1.5.3 Global Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)

2 GLOBAL DRUGS FOR THE TREATMENT OF ASTHMA COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Drugs for the Treatment of Asthma Market Competition by Manufacturers
  2.1.1 Global Drugs for the Treatment of Asthma Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Global Drugs for the Treatment of Asthma Revenue and Share by Manufacturers (2015 and 2016)
2.2 Global Drugs for the Treatment of Asthma (Volume and Value) by Type
  2.2.1 Global Drugs for the Treatment of Asthma Sales and Market Share by Type (2011-2021)
  2.2.2 Global Drugs for the Treatment of Asthma Revenue and Market Share by Type (2011-2021)
2.3 Global Drugs for the Treatment of Asthma (Volume and Value) by Regions
  2.3.1 Global Drugs for the Treatment of Asthma Sales and Market Share by Regions (2011-2021)
  2.3.2 Global Drugs for the Treatment of Asthma Revenue and Market Share by Regions (2011-2021)
2.4 Global Drugs for the Treatment of Asthma (Volume) by Application

3 NORTH AMERICA DRUGS FOR THE TREATMENT OF ASTHMA (VOLUME, VALUE AND SALES PRICE

3.1 North America Drugs for the Treatment of Asthma Sales and Value (2011-2021)
  3.1.1 North America Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
  3.1.2 North America Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
  3.1.3 North America Drugs for the Treatment of Asthma Sales Price Trend (2011-2021)
3.2 North America Drugs for the Treatment of Asthma Sales and Market Share by Manufacturers
3.3 North America Drugs for the Treatment of Asthma Sales and Market Share by Type
3.4 North America Drugs for the Treatment of Asthma Sales and Market Share by Applications

4 CHINA DRUGS FOR THE TREATMENT OF ASTHMA (VOLUME, VALUE AND SALES PRICE

4.1 China Drugs for the Treatment of Asthma Sales and Value (2011-2021)
  4.1.1 China Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
  4.1.2 China Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
  4.1.3 China Drugs for the Treatment of Asthma Sales Price Trend (2011-2021)
4.2 China Drugs for the Treatment of Asthma Sales and Market Share by Manufacturers
4.3 China Drugs for the Treatment of Asthma Sales and Market Share by Type
4.4 China Drugs for the Treatment of Asthma Sales and Market Share by Applications

5 EUROPE DRUGS FOR THE TREATMENT OF ASTHMA (VOLUME, VALUE AND SALES PRICE

5.1 Europe Drugs for the Treatment of Asthma Sales and Value (2011-2021)
  5.1.1 Europe Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
  5.1.2 Europe Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
  5.1.3 Europe Drugs for the Treatment of Asthma Sales Price Trend (2011-2021)
5.2 Europe Drugs for the Treatment of Asthma Sales and Market Share by Manufacturers
5.3 Europe Drugs for the Treatment of Asthma Sales and Market Share by Type
5.4 Europe Drugs for the Treatment of Asthma Sales and Market Share by Applications

6 JAPAN DRUGS FOR THE TREATMENT OF ASTHMA (VOLUME, VALUE AND SALES PRICE

6.1 Japan Drugs for the Treatment of Asthma Sales and Value (2011-2021)
  6.1.1 Japan Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
  6.1.2 Japan Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
  6.1.3 Japan Drugs for the Treatment of Asthma Sales Price Trend (2011-2021)
6.2 Japan Drugs for the Treatment of Asthma Sales and Market Share by Manufacturers
6.3 Japan Drugs for the Treatment of Asthma Sales and Market Share by Type
6.4 Japan Drugs for the Treatment of Asthma Sales and Market Share by Applications

7 SOUTHEAST ASIA DRUGS FOR THE TREATMENT OF ASTHMA (VOLUME, VALUE AND SALES PRICE

7.1 Southeast Asia Drugs for the Treatment of Asthma Sales and Value (2011-2021)
  7.1.1 Southeast Asia Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
  7.1.2 Southeast Asia Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
  7.1.3 Southeast Asia Drugs for the Treatment of Asthma Sales Price Trend (2011-2021)
7.2 Southeast Asia Drugs for the Treatment of Asthma Sales and Market Share by Manufacturers
7.3 Southeast Asia Drugs for the Treatment of Asthma Sales and Market Share by Type
7.4 Southeast Asia Drugs for the Treatment of Asthma Sales and Market Share by Applications

8 INDIA DRUGS FOR THE TREATMENT OF ASTHMA (VOLUME, VALUE AND SALES PRICE

8.1 India Drugs for the Treatment of Asthma Sales and Value (2011-2021)
  8.1.1 India Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
  8.1.2 India Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
  8.1.3 India Drugs for the Treatment of Asthma Sales Price Trend (2011-2021)
8.2 India Drugs for the Treatment of Asthma Sales and Market Share by Manufacturers
8.3 India Drugs for the Treatment of Asthma Sales and Market Share by Type
8.4 India Drugs for the Treatment of Asthma Sales and Market Share by Applications

9 GLOBAL DRUGS FOR THE TREATMENT OF ASTHMA MANUFACTURERS ANALYSIS

9.1 Novartis
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.1.2.1 Beta2 Adrenergic Receptor Agonist
    9.1.2.2 M Cholinergic Receptor Antagonist
  9.1.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Company One (2015 and 2016)
9.2 Pfizer, Inc.
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.2.2.1 Beta2 Adrenergic Receptor Agonist
    9.2.2.2 M Cholinergic Receptor Antagonist
  9.2.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Company One (2015 and 2016)
9.3 Roche
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.3.2.1 Beta2 Adrenergic Receptor Agonist
    9.3.2.2 M Cholinergic Receptor Antagonist
  9.3.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Company One (2015 and 2016)
9.4 Sanofi
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.4.2.1 Beta2 Adrenergic Receptor Agonist
    9.4.2.2 M Cholinergic Receptor Antagonist
  9.4.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Company One (2015 and 2016)
9.5 Merck & Co., Inc.
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.5.2.1 Beta2 Adrenergic Receptor Agonist
    9.5.2.2 M Cholinergic Receptor Antagonist
  9.5.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Company One (2015 and 2016)
9.6 GlaxoSmithKline plc
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.6.2.1 Beta2 Adrenergic Receptor Agonist
    9.6.2.2 M Cholinergic Receptor Antagonist
  9.6.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Company One (2015 and 2016)
9.7 Johnson & Johnson
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Company One (2015 and 2017)
9.8 AstraZeneca plc.
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Company One (2015 and 2018)
9.9 Eli Lilly and Company
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Company One (2015 and 2019)
9.10 Abbvie
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Drugs for the Treatment of Asthma Product Type and Technology
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 Drugs for the Treatment of Asthma Sales, Revenue, Price of Company One (2015 and 2021)
9.11 AMGen
9.12 Teva Pharmaceutical Industries Ltd.
9.13 Bayer AG
9.14 Bristol-Myers Squibb
9.15 Astellas Pharma
9.16 Daiichi Sankyo
9.17 Abbott Laboratories
9.18 Yangtze River Pharmaceutical Group
9.19 BAX
9.20 Taishō Seiyaku Kabushiki-gaisha

10 DRUGS FOR THE TREATMENT OF ASTHMA TECHNOLOGY AND DEVELOPMENT TREND

10.1 Drugs for the Treatment of Asthma Technology Analysis
10.2 Drugs for the Treatment of Asthma Technology Development Trend

11 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Drugs for the Treatment of Asthma
Table Classification of Drugs for the Treatment of Asthma
Figure Global Sales Market Share of Drugs for the Treatment of Asthma by Type in 2015
Figure Beta2 Adrenergic Receptor Agonist Picture
Figure M Cholinergic Receptor Antagonist Picture
Figure Drugs that Affect Leukotrienes Picture
Figure Glucocorticoid Drugs Picture
Figure Phosphodiesterase Inhibitors Picture
Table Applications of Drugs for the Treatment of Asthma
Figure Global Sales Market Share of Drugs for the Treatment of Asthma by Applications in 2015
Figure First Level Hospital Examples
Figure Two Level Hospital Examples
Figure Three Level Hospital Examples
Figure Others Examples
Figure North America Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Figure China Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Figure Europe Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Figure Japan Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Figure India Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Table Global Drugs for the Treatment of Asthma Sales, Revenue and Price (2011-2021)
Figure Global Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
Figure Global Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Table Global Drugs for the Treatment of Asthma Sales of Key Manufacturers (2015 and 2016)
Table Global Drugs for the Treatment of Asthma Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Drugs for the Treatment of Asthma Sales Share by Manufacturers
Figure 2016 Drugs for the Treatment of Asthma Sales Share by Manufacturers
Table Global Drugs for the Treatment of Asthma Revenue by Manufacturers (2015 and 2016)
Table Global Drugs for the Treatment of Asthma Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Drugs for the Treatment of Asthma Revenue Share by Manufacturers
Table 2016 Global Drugs for the Treatment of Asthma Revenue Share by Manufacturers
Table Global Drugs for the Treatment of Asthma Sales and Market Share by Type (2011-2021)
Table Global Drugs for the Treatment of Asthma Sales Share by Type (2011-2021)
Figure Sales Market Share of Drugs for the Treatment of Asthma by Type (2011-2021)
Figure Global Drugs for the Treatment of Asthma Sales Growth Rate by Type (2011-2021)
Table Global Drugs for the Treatment of Asthma Revenue and Market Share by Type (2011-2021)
Table Global Drugs for the Treatment of Asthma Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Drugs for the Treatment of Asthma by Type (2011-2021)
Figure Global Drugs for the Treatment of Asthma Revenue Growth Rate by Type (2011-2021)
Table Global Drugs for the Treatment of Asthma Sales and Market Share by Regions (2011-2021)
Table Global Drugs for the Treatment of Asthma Sales Share by Regions (2011-2021)
Figure Sales Market Share of Drugs for the Treatment of Asthma by Regions (2011-2021)
Figure Global Drugs for the Treatment of Asthma Sales Growth Rate by Regions (2011-2021)
Table Global Drugs for the Treatment of Asthma Revenue and Market Share by Regions (2011-2021)
Table Global Drugs for the Treatment of Asthma Revenue Share by Regions (2011-2021)
Figure Revenue Market Share of Drugs for the Treatment of Asthma by Regions (2011-2021)
Figure Global Drugs for the Treatment of Asthma Revenue Growth Rate by Regions (2011-2021)
Table Global Drugs for the Treatment of Asthma Sales and Market Share by Application (2011-2021)
Table Global Drugs for the Treatment of Asthma Sales Share by Application (2011-2021)
Figure Sales Market Share of Drugs for the Treatment of Asthma by Application (2011-2021)
Figure Global Drugs for the Treatment of Asthma Sales Growth Rate by Application (2011-2021)
Figure North America Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
Figure North America Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Figure North America Drugs for the Treatment of Asthma Sales Price Trend (2011-2021)
Table North America Drugs for the Treatment of Asthma Sales by Manufacturers (2015 and 2016)
Table North America Drugs for the Treatment of Asthma Market Share by Manufacturers (2015 and 2016)
Table North America Drugs for the Treatment of Asthma Sales by Type (2015 and 2016)
Table North America Drugs for the Treatment of Asthma Market Share by Type (2015 and 2016)
Table North America Drugs for the Treatment of Asthma Sales by Applications (2015 and 2016)
Table North America Drugs for the Treatment of Asthma Market Share by Applications (2015 and 2016)
Figure Europe Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
Figure Europe Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Figure Europe Drugs for the Treatment of Asthma Sales Price Trend (2011-2021)
Table Europe Drugs for the Treatment of Asthma Sales by Manufacturers (2015 and 2016)
Table Europe Drugs for the Treatment of Asthma Market Share by Manufacturers (2015 and 2016)
Table Europe Drugs for the Treatment of Asthma Sales by Type (2015 and 2016)
Table Europe Drugs for the Treatment of Asthma Market Share by Type (2015 and 2016)
Table Europe Drugs for the Treatment of Asthma Sales by Applications (2015 and 2016)
Table Europe Drugs for the Treatment of Asthma Market Share by Applications (2015 and 2016)
Figure China Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
Figure China Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Figure China Drugs for the Treatment of Asthma Sales Price Trend (2011-2021)
Table China Drugs for the Treatment of Asthma Sales by Manufacturers (2015 and 2016)
Table China Drugs for the Treatment of Asthma Market Share by Manufacturers (2015 and 2016)
Table China Drugs for the Treatment of Asthma Sales by Type (2015 and 2016)
Table China Drugs for the Treatment of Asthma Market Share by Type (2015 and 2016)
Table China Drugs for the Treatment of Asthma Sales by Applications (2015 and 2016)
Table China Drugs for the Treatment of Asthma Market Share by Applications (2015 and 2016)
Figure Japan Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
Figure Japan Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Figure Japan Drugs for the Treatment of Asthma Sales Price Trend (2011-2021)
Table Japan Drugs for the Treatment of Asthma Sales by Manufacturers (2015 and 2016)
Table Japan Drugs for the Treatment of Asthma Market Share by Manufacturers (2015 and 2016)
Table Japan Drugs for the Treatment of Asthma Sales by Type (2015 and 2016)
Table Japan Drugs for the Treatment of Asthma Market Share by Type (2015 and 2016)
Table Japan Drugs for the Treatment of Asthma Sales by Applications (2015 and 2016)
Table Japan Drugs for the Treatment of Asthma Market Share by Applications (2015 and 2016)
Figure India Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
Figure India Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Figure India Drugs for the Treatment of Asthma Sales Price Trend (2011-2021)
Table India Drugs for the Treatment of Asthma Sales by Manufacturers (2015 and 2016)
Table India Drugs for the Treatment of Asthma Market Share by Manufacturers (2015 and 2016)
Table India Drugs for the Treatment of Asthma Sales by Type (2015 and 2016)
Table India Drugs for the Treatment of Asthma Market Share by Type (2015 and 2016)
Table India Drugs for the Treatment of Asthma Sales by Applications (2015 and 2016)
Table India Drugs for the Treatment of Asthma Market Share by Applications (2015 and 2016)
Figure Southeast Asia Drugs for the Treatment of Asthma Sales and Growth Rate (2011-2021)
Figure Southeast Asia Drugs for the Treatment of Asthma Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Drugs for the Treatment of Asthma Sales Price Trend (2011-2021)
Table Southeast Asia Drugs for the Treatment of Asthma Sales by Manufacturers (2015 and 2016)
Table Southeast Asia Drugs for the Treatment of Asthma Market Share by Manufacturers (2015 and 2016)
Table Southeast Asia Drugs for the Treatment of Asthma Sales by Type (2015 and 2016)
Table Southeast Asia Drugs for the Treatment of Asthma Market Share by Type (2015 and 2016)
Table Southeast Asia Drugs for the Treatment of Asthma Sales by Applications (2015 and 2016)
Table Southeast Asia Drugs for the Treatment of Asthma Market Share by Applications (2015 and 2016)
Table Novartis Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Novartis (2015 and 2016)
Table Pfizer, Inc. Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Pfizer, Inc. (2015 and 2016)
Table Roche Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Roche (2015 and 2016)
Table Sanofi Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Sanofi (2015 and 2016)
Table Merck & Co., Inc. Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Merck & Co., Inc. (2015 and 2016)
Table GlaxoSmithKline plc Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
Table AstraZeneca plc. Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of AstraZeneca plc. (2015 and 2016)
Table Eli Lilly and Company Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Eli Lilly and Company (2015 and 2016)
Table Abbvie Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Abbvie (2015 and 2016)
Table AMGen Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of AMGen (2015 and 2016)
Table Teva Pharmaceutical Industries Ltd. Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Teva Pharmaceutical Industries Ltd. (2015 and 2016)
Table Bayer AG Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Bayer AG (2015 and 2016)
Table Bristol-Myers Squibb Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)
Table Astellas Pharma Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Astellas Pharma (2015 and 2016)
Table Daiichi Sankyo Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Daiichi Sankyo (2015 and 2016)
Table Abbott Laboratories Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Abbott Laboratories (2015 and 2016)
Table Yangtze River Pharmaceutical Group Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Yangtze River Pharmaceutical Group (2015 and 2016)
Table BAX Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of BAX (2015 and 2016)
Table Taishō Seiyaku Kabushiki-gaisha Basic Information List
Table Drugs for the Treatment of Asthma Sales, Revenue, Price of Taishō Seiyaku Kabushiki-gaisha (2015 and 2016)